Puma Biotechnology Inc — datos financieros trimestrales (NASDAQ:PBYI) | MetaTrader

Ver el calendario completo

Financials

Visión general Informes Estadísticas

Flujo de caja de las actividades operativas 15.61 M3.61 M14.08 M9.69 M14.42 M 41.8 M Flujo de caja de las actividades de inversión -2.32 M1.53 M-11.25 M506 K-26.98 M -36.19 M Flujo de caja de las actividades financieras -11.33 M-11.33 M-11.2 M-11.33 M-11.33 M -45.2 M Flujo de caja libre 15.59 M3.55 M14.06 M9.66 M14.46 M 41.73 M

Puma Biotechnology Inc

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

Noticias

Editas (EDIT) Up 3.8% Since Last Earnings Report: Can It Continue?

Agios Pharmaceuticals (AGIO) Moves 14.3% Higher: Will This Strength Last?

Puma Biotechnology 4T 2025: ingresos de NERLYNX suben 15%

Puma Biotechnology reporta sólidos resultados del cuarto trimestre de 2025

Puma Biotechnology Stock Declines More Than 9% in a Month: Here's Why

IRWD vs. PBYI: Which Small-Cap Biotech Stock Is a Better Buy?

Puma Biotech en Conferencia TD Cowen: Crecimiento y Disciplina Financiera

PBYI Q4 Earnings & Sales Beat Estimates, Stock Down on Weak 2026 View

Puma Biotechnology, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:PBYI) 2026-02-27

Puma Biotech (PBYI) Q4 Earnings and Revenues Beat Estimates

Jazz Pharmaceuticals (JAZZ) Beats Q4 Earnings and Revenue Estimates

Exelixis (EXEL) Q4 Earnings and Revenues Beat Estimates